Affluent Medical SAS
PAR:AFME

Watchlist Manager
Affluent Medical SAS Logo
Affluent Medical SAS
PAR:AFME
Watchlist
Price: 2.81 EUR 0.36% Market Closed
Market Cap: €110.6m

Wall Street
Price Targets

AFME Price Targets Summary
Affluent Medical SAS

Wall Street analysts forecast AFME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFME is 3.33 EUR with a low forecast of 2.53 EUR and a high forecast of 3.99 EUR.

Lowest
Price Target
2.53 EUR
10% Downside
Average
Price Target
3.33 EUR
19% Upside
Highest
Price Target
3.99 EUR
42% Upside
Affluent Medical SAS Competitors:
Price Targets
PLC
PLC SpA
31% Upside

Revenue
Forecast

94% / Year
Past Growth
54% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
94% / Year
Past Growth
54% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 7 years the compound annual growth rate for Affluent Medical SAS's revenue is 94%. The projected CAGR for the next 3 years is 54%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFME's stock price target?
Price Target
3.33 EUR

According to Wall Street analysts, the average 1-year price target for AFME is 3.33 EUR with a low forecast of 2.53 EUR and a high forecast of 3.99 EUR.

What is Affluent Medical SAS's Revenue forecast?
Projected CAGR
54%

For the last 7 years the compound annual growth rate for Affluent Medical SAS's revenue is 94%. The projected CAGR for the next 3 years is 54%.

Back to Top